Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Chi Wen Luo"'
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 2, Pp 863-867 (2023)
Background: Lymphangioma is unusual malformation of the lymphatic system and rarely occurred in adults below diaphragm. Lymphangioma in small intestine sometimes caused unspecific symptoms and even bleeding, however, this area was most difficult for
Externí odkaz:
https://doaj.org/article/2e5eeb08090f48a5a37549ce80f8b7ef
Autor:
Cheng-Che Wu, Mei-Ren Pan, Shen-Liang Shih, Jun-Ping Shiau, Chun-Chieh Wu, Shu-Jyuan Chang, Chieh-Ni Kao, Fang-Ming Chen, Ming-Feng Hou, Chi-Wen Luo
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 163, Iss , Pp 114732- (2023)
Triple-negative breast cancer (TNBC) is characterized by the loss of expression of several biomarkers, which limits treatment strategies for the disease. In recent years, immunotherapy has shown promising results in the treatment of various tumors. E
Externí odkaz:
https://doaj.org/article/11e18ab5fac54dc59f444e1ffcc34b0b
Autor:
YIN-CHOU HSU, CHI-WEN LUO, SHU-JYUAN CHANG, CHIAO-YING LAI, YU-TZU YANG, YI-ZI CHEN, WANG-TA LIU, CHUN-CHIEH WU, CHEUK-KWAN SUN, MING-FENG HOU, MEI-REN PAN
Publikováno v:
Cancer Genomics & Proteomics (1109-6535); Sep/Oct2024, Vol. 21 Issue 5, p523-532, 10p
Autor:
Tsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Tzer-Ming Chuang, Yuh-Ching Gau, Shih-Feng Cho, Yi-Chang Liu, Hui-Hua Hsiao, Li-Tzong Chen, Mei-Ren Pan, Hui-Ching Wang, Sin-Hua Moi
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 691 (2023)
Head and neck cancers (HNCs) are among the ten leading malignancies worldwide. Despite significant progress in all therapeutic modalities, predictive biomarkers, and targeted therapies for HNCs are limited and the survival rate is unsatisfactory. The
Externí odkaz:
https://doaj.org/article/4ed27ffb8415412c8bc1882fbbe58848
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 5, Pp 494-495 (2022)
Externí odkaz:
https://doaj.org/article/014428fad76d4909ac0b165383c63453
Autor:
CHIEH-NI KAO, CHIA-CHI CHEN, WAN-LING CHU, CHI-WEN LUO, WEI-LUN HUANG, SIN-HUA MOI, MING-FENG HOU, MEI-REN PAN
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1143-1151, 9p
Autor:
Jun-Ping Shiau, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih, Chi-Wen Luo
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1789 (2021)
Triple-negative breast cancer (TNBC) remains a significant clinical challenge because of its high vascularity and metastatic and recurrent rates. Tumor angiogenesis is considered an important mediator in the regulation of tumor cell survival and meta
Externí odkaz:
https://doaj.org/article/2bd55e6e0582488691e5df6ca9e96cb4
Autor:
Fan-Yen Lee, Chi-Wen Luo, Christopher Glenn Wallace, Kuan-Hung Chen, Jiunn-Jye Sheu, Tsung-Cheng Yin, Han-Tan Chai, Hon-Kan Yip
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss , Pp - (2019)
Background: This study tested the hypothesis that intramuscular injections of erythropoietin (EPO) and endothelial progenitor cells (EPC) to critical limb ischemia (CLI; primary treatment site) could also improve heart function in rat after acute myo
Externí odkaz:
https://doaj.org/article/51d4a61368194baf81d8b7cb4883e419
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 6; Pages: 5583
The treatment provided for breast cancer depends on the expression of hormone receptors, human epidermal growth factor receptor-2 (HER2), and cancer staging. Surgical intervention, along with chemotherapy or radiation therapy, is the mainstay of trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645ec46003312f716b4b78a9f5d6784e
Autor:
WEI-LUN HUANG, CHI-WEN LUO, HUEI-SHAN LIN, CHAO-MING HUNG, FANG-MING CHEN, SIN-HUA MOI, MEI-REN PAN
Publikováno v:
Cancer Genomics & Proteomics (1109-6535); Nov/Dec2023, Vol. 20 Issue 6, p582-591, 10p